Follow-up program for people with esophageal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a standard follow-up plan for people who have esophageal cancer and received a certain amount of radiation. It may help your care team monitor side effects and catch health changes early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with esophageal (food pipe) cancer
- You are currently receiving or have received radiation therapy over 40 Gy
- You must be able and willing to follow the study’s follow-up plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often people who had surgery for esophageal or stomach cancer should have follow-up tests. It aims to find the best way to monitor you after treatment.
This Phase 3 trial studies giving combined chemotherapy and radiation to treat esophageal cancer that has returned after earlier surgery and/or prior treatments. It may help control the cancer in the area where it comes back, especially when the surgical margins were not fully clear or the cancer is outside the original radiation field.
This trial tests whether adding the immunotherapy drug toripalimab and the chemotherapy pill capecitabine after standard chemoradiotherapy can help prevent esophageal cancer from coming back. It's for people with squamous cell esophageal cancer that hasn't spread far and who have just finished chemoradiotherapy.
This trial compares two approaches for people with esophageal cancer that has shrunk or disappeared after initial chemotherapy combined with immunotherapy. It looks at whether adding targeted radiation (DCRT) or surgery is better. The goal is to find the most effective next step for eligible patients.
This trial studies a standard follow-up plan to help you stay on track after radiation treatment for lung cancers or certain related conditions. It may help your care team monitor symptoms and outcomes in a consistent way.
This trial tests a standard follow-up program for people with breast cancer who are getting radiotherapy. It aims to see how well the program supports patients after treatment.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.